|Bid||2,602.00 x 0|
|Ask||2,603.00 x 0|
|Day's range||2,573.00 - 2,724.00|
|52-week range||1,773.50 - 3,764.00|
|Beta (3Y monthly)||1.01|
|PE ratio (TTM)||20.19|
|Earnings date||22 Aug 2019|
|Forward dividend & yield||0.18 (0.67%)|
|1y target est||54.44|
The total purchase price was equivalent to about 25 times Sophos’s free cash flow, which was well above valuations in the mid- to high-teens given to US security software makers such as Palo Alto, Fortinet and Checkpoint, said Morgan Stanley. ● JPMorgan Cazenove downgraded Ocado from “neutral” to “underweight” with a £10.50 target price. Ocado’s £9bn valuation “is already stretched” based on its pipeline of licensed warehouses and its Marks and Spencer joint venture, said JPMorgan.
The FTSE 100 shed 1.1%, while the FTSE 250 was roughly flat. Companies that book a major chunk of their earnings in dollars, including Diageo and Unilever dropped after Merkel said a solution to the Irish border problem could be found before Britain leaves the European Union on Oct. 31. Imperial Brands lost 2.7%, as the stock also traded ex-dividend.
DUBAI/ABU DHABI (Reuters) - Two groups, including one backed by China's Fosun , have made competing offers to buy a 40% stake in London-listed NMC Health worth up to $1.9 billion (£1.5 billion), four sources familiar with the deal said. The target stake is jointly owned by the chairman of Abu Dhabi-based investment firm KBBO Group, Khalifa Butti Bin Omeir, UAE-based businessman Saeed Bin Butti Al Qebaisi, and Infinite Investment, a vehicle linked to the two men. NMC Health's businesses include an extended portfolio of hospitals, day surgery centres, clinics and pharmacies across the UAE.